Channel
Updated: 2026-07-28
2026.07.28 15:56:13 기업명: 한미약품(시가총액: 4조 7,977억) A128940 보고서명: 연결재무제표기준영업(잠정)실적(공정공시) 매출액 : 4,672억(예상치 : 4,466억+/ 5%) 영업익 : 1,311억(예상치 : 1,102억/ +19%) 순이익 : 833억(예상치 : 969억/ -14%) 최근…
[한국거래소] 코스닥시장 매매거래 일시중단(1단계 CB 발동) https://kind.krx.co.kr/common/disclsviewer.do?method=search&acptno=20260728000312 ● 일자 및 시각: 2026-07-28 12:01:12 ● 내용 - 코스닥종합주가지수가 전일종가지수 대비 8% 이…
Media post
Media post
[키움 신민수] 마이다스에셋자산운용의 MIDAS 바이오헬스케어액티브 ETF 출시 - MIDAS 바이오헬스케어액티브 ETF(0214M0) 오늘(28일) 상장 예정 - 주요 구성 종목으로는 셀트리온 9.8%, 삼성바이오로직스 9.3%, 알테오젠 9.1%, 에스티팜 7.8%, 리가켐바이오 7.6%, 에이비엘바이오 7.2% 등이…
A head-to-head of how Backpack and Phantom advertise on Telegram — the Solana-rooted exchange-and-wallet versus the leading self-custody wallet, their creative and targeting differences, and what the Telegram Ads Spy archive reveals.
How advertisers reach Belgian audiences on Telegram — one of Europe's toughest gambling and ad-restriction regimes pushing operators offshore, a Dutch/French/German language split, and EU-regulated crypto and trading.
How advertisers reach Irish audiences on Telegram — an English-speaking EU member inside the UK-Ireland creative pool, a fintech and tech-HQ hub, EU-regulated crypto and forex, and offshore gambling under a tightening licensing regime.
How advertisers reach Korean audiences on Telegram — the real-name banking regime that pushes activity offshore, one of the world's most intense retail-crypto cultures, gaming and esports adjacency, and won-denominated payment friction.
Flags — the regions we asked our observer pool for while recording this ad in this channel. That is a label on our request, not a confirmed place of viewing: when no account is available in the requested country the pool silently substitutes another and does not say so. It is not the advertiser's targeting country either. We stopped requesting the region on {date}, so newer creatives carry no flags at all. The channel's main country (by its language) is highlighted in blue; regions under 5% are collapsed into +N.
https://n.news.naver.com/article/014/0005553660?sid=101
26/07/28 (화) 키움 제약바이오 데일리 💊 [제약/바이오 Analyst 허혜민, RA 김종현] 키움 제약/바이오/의료기기 소식통: t.me/huhpharm <📈 주요 지수 등락> * 코스피 +0.97% vs 코스피 제약 +0.99% * 코스닥 +2.22% vs 코스닥 제약 +1.37% * S&P500 +0.0…
임상시료부터 프리PPQ, PPQ 배치까지 생산이 장기간 이뤄진 특정 품목이 2분기에 출하되면서 원가가 한번에 반영됨으로써 약 57억원 이상의 원가가 상승했습니다 일회적 요인인 해당 원가상승 57억원을 제외하면 영업이익은 240억원, OPM은 22.1%입니다
제약/바이오 뉴스, 업데이트, 발간자료 공유